Proceedings: Effect of dopamine-beta-hydroxylase inhibitors and centrally administered noradrenaline on (+)-amphetamine anorexia in mice.
D000818:Animals; D000855:Anorexia / Q000139:chemically induced*; D002552:Cerebral Ventricles; D003913:Dextroamphetamine / Q000494:pharmacology*; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors*; D004357:Drug Synergism; D001068:Feeding and Eating Disorders / Q000139:chemically induced*; D006801:Humans; D007267:Injections; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology*
D004299:Dopamine beta-Hydroxylase; D003913:Dextroamphetamine; D009638:Norepinephrine